Paper36926710
Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease.
Hertzog N and 1 other. Neural Regen Res, 2023. Cited by 19 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease. Papers, record 36926710. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36926710
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References131
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20,093,502 | MCP-1/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20093502 | PubMed |
| 2 | 29,202,483 | PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models. | J Clin Invest | 2018 | https://conductscience.org/library/papers/29202483 | PubMed |
| 3 | 20,591,826 | Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X. | Hum Mol Genet | 2010 | https://conductscience.org/library/papers/20591826 | PubMed |
| 4 | 25,150,498 | Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. | Nat Med | 2014 | https://conductscience.org/library/papers/25150498 | PubMed |
| 5 | 33,960,567 | Loss of function MPZ mutation causes milder CMT1B neuropathy. | J Peripher Nerv Syst | 2021 | https://conductscience.org/library/papers/33960567 | PubMed |
| 6 | 30,995,221 | Schwann cells ER-associated degradation contributes to myelin maintenance in adult nerves and limits demyelination in CMT1B mice. | PLoS Genet | 2019 | https://conductscience.org/library/papers/30995221 | PubMed |
| 7 | 16,495,463 | Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. | J Neurosci | 2006 | https://conductscience.org/library/papers/16495463 | PubMed |
| 8 | 31,017,387 | HSP90 Inhibitor, NVP-AUY922, Improves Myelination in Vitro and Supports the Maintenance of Myelinated Axons in Neuropathic Mice. | ACS Chem Neurosci | 2019 | https://conductscience.org/library/papers/31017387 | PubMed |
| 9 | 21,168,501 | The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration. | Neurobiol Dis | 2011 | https://conductscience.org/library/papers/21168501 | PubMed |
| 10 | 35,221,918 | The Role of c-Jun and Autocrine Signaling Loops in the Control of Repair Schwann Cells and Regeneration. | Front Cell Neurosci | 2021 | https://conductscience.org/library/papers/35221918 | PubMed |
| 11 | 29,431,744 | A histone deacetylase 3-dependent pathway delimits peripheral myelin growth and functional regeneration. | Nat Med | 2018 | https://conductscience.org/library/papers/29431744 | PubMed |
| 12 | 24,646,194 | PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies. | Orphanet J Rare Dis | 2014 | https://conductscience.org/library/papers/24646194 | PubMed |
| 13 | 19,546,221 | P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19546221 | PubMed |
| 14 | 33,692,503 | AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy. | Gene Ther | 2021 | https://conductscience.org/library/papers/33692503 | PubMed |
| 15 | 30,657,878 | Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis. | Brain | 2019 | https://conductscience.org/library/papers/30657878 | PubMed |
| 16 | 31,638,085 | Unfolded protein response in myelin disorders. | Neural Regen Res | 2020 | https://conductscience.org/library/papers/31638085 | PubMed |
| 17 | 22,689,911 | MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B. | Brain | 2012 | https://conductscience.org/library/papers/22689911 | PubMed |
| 18 | 33,063,822 | Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease. | Clin Sci (Lond) | 2020 | https://conductscience.org/library/papers/33063822 | PubMed |
| 19 | 22,966,146 | Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. | Ann Rheum Dis | 2012 | https://conductscience.org/library/papers/22966146 | PubMed |
| 20 | 25,429,154 | PMP22 is critical for actin-mediated cellular functions and for establishing lipid rafts. | J Neurosci | 2014 | https://conductscience.org/library/papers/25429154 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,799,012 | Pathogenic LRSAM1 RING Domain Variants Disrupt Intracellular Protein Localization in Charcot-Marie-Tooth Disease Type 2P. | Hum Mutat | 2026 | https://conductscience.org/library/papers/42799012 | PubMed |
| 42,656,289 | Novel MORC2 variants in Charcot-Marie-Tooth disease type 2Z: genetic and functional insights. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42656289 | PubMed |
| 42,159,481 | Peripheral Myelin Protein-22 and Its Prominence in Charcot-Marie-Tooth Disease. | Chem Rev | 2026 | https://conductscience.org/library/papers/42159481 | PubMed |
| 41,757,265 | Case Report: Recurrent stroke-like episodes triggered by high-altitude exposure in X-linked charcot-marie-tooth disease. | Front Genet | 2026 | https://conductscience.org/library/papers/41757265 | PubMed |
| 41,551,139 | A comparative phenotypic analysis of a heterogeneous PMP22 cohort presenting with persistent toe-walking versus classic PMP22-related Neuropathies. | Glob Med Genet | 2026 | https://conductscience.org/library/papers/41551139 | PubMed |
| 41,507,260 | Metabolic signatures in sciatic nerve of PMP22 transgenic rats provide insights into the pathogenesis of charcot-marie-tooth disease type 1 A. | Sci Rep | 2026 | https://conductscience.org/library/papers/41507260 | PubMed |
| 40,940,747 | Pathologic and Therapeutic Schwann Cells. | Cells | 2025 | https://conductscience.org/library/papers/40940747 | PubMed |
| 40,864,398 | The current status of Charcot-Marie-Tooth disease type 1 A treatment. | Acta Neurol Belg | 2025 | https://conductscience.org/library/papers/40864398 | PubMed |
| 39,639,332 | A fully human IgG1 antibody targeting connexin 32 extracellular domain blocks CMTX1 hemichannel dysfunction in an in vitro model. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/39639332 | PubMed |
| 39,464,795 | Case Report: Charcot-marie-tooth disease caused by a de novo MORC2 gene mutation - novel insights into pathogenicity and treatment. | Front Genet | 2024 | https://conductscience.org/library/papers/39464795 | PubMed |
| 39,457,026 | Monitoring Myelin Lipid Composition and the Structure of Myelinated Fibers Reveals a Maturation Delay in CMT1A. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39457026 | PubMed |
| 39,328,666 | A Case of Charcot-Marie-Tooth Disease Causing Colitis and Electrolyte Imbalances. | Cureus | 2024 | https://conductscience.org/library/papers/39328666 | PubMed |
| 39,143,067 | Intermediate phenotype between CMT2Z and DIGFAN associated with a novel MORC2 variant: a case report. | Hum Genome Var | 2024 | https://conductscience.org/library/papers/39143067 | PubMed |
| 38,051,345 | Upper and lower limb tremor in Charcot-Marie-Tooth neuropathy type 1A and the implications for standing balance. | J Neurol | 2024 | https://conductscience.org/library/papers/38051345 | PubMed |
| 37,887,034 | In Vivo Ultrafast Doppler Imaging Combined with Confocal Microscopy and Behavioral Approaches to Gain Insight into the Central Expression of Peripheral Neuropathy in Trembler-J Mice. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37887034 | PubMed |
| 37,488,868 | The MORC2 p.S87L mutation reduces proliferation of pluripotent stem cells derived from a patient with the spinal muscular atrophy-like phenotype by inhibiting proliferation-related signaling pathways. | Neural Regen Res | 2024 | https://conductscience.org/library/papers/37488868 | PubMed |
| 37,298,723 | Role of SNAREs and Rabs in Myelin Regulation. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298723 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36926710
GET https://conductscience.org/api/papers/v1/36926710/references?page=2